Team:UCL/Labbook/Week12
From 2013.igem.org
Line 59: | Line 59: | ||
<div class="full_row"> | <div class="full_row"> | ||
- | |||
<div class="gap"> | <div class="gap"> | ||
</div> | </div> | ||
+ | <p class="body_text"> | ||
<b>Bacterial Lab</b> | <b>Bacterial Lab</b> | ||
</p> | </p> | ||
Line 683: | Line 683: | ||
<div class="full_row"> | <div class="full_row"> | ||
+ | <div class="gap"> | ||
+ | </div> | ||
<p class="body_text"> | <p class="body_text"> | ||
<b>Mammalian Lab</b> | <b>Mammalian Lab</b> |
Revision as of 12:29, 3 October 2013
Lab Weeks
Week 1 | Week 2 | Week 3 | Week 4 | Week 5 | Week 6 | Week 7 | Week 8 | Week 9 | Week 10 | Week 11 | Week 12 | Week 13 | Week 14 | Week 15 | Week 16 | Week 17 | Week 18 | Week 19 | Week 20
Week 12
Bacterial Lab
19th August - pSB1C3 streaked plates (well 23.O) were retrieved from 30C incubator. Colony growth visible indicating successful transformation. Colonies were expected to be red in colour, however this was not observed.
Plate (competent cell vial) | Colony Count |
---|---|
10 | 50+ |
20 | 50+ |
A single colony from each plate was then inoculated in LB in order to later prepare glycerol stocks.
iGEM 2012 boxes were searched for pSB1C3. Transformation was carried out and then selective plates were spread, incubated o/n @37C.
Innoculations of the following were carried out in 2mL LB:
· IRRE+PC+RBS (pSB1C3) (2x in 2mL LB) -> 2ul and 5ul -> incu-shaker
· RFP+pSB1C3 (scooped from plates) (2x in 2mL LB) -> incu-shaker
^ 1.5mL miniprep, 0.5mL glycerol stock for following day (20th)
20th August - Plates taken from incubation:
Competent cells transformed with plasmid: Colony growth -> cells have successfully taken up plamid.
Negative control (only competent cells): Colony growth -> Most likely problems with Chloramphenicol.
Will therefore re-make chloramphenicol
Plate (pSB1C3+) | Colony Count |
---|---|
NUC | 5 |
LAC | 20 |
LAC | 15 |
LAC2 | 10 |
CURL1 | 30 |
Control | 50 |
take from incu-shaker:
IRRE+PC+RBS ( pSB1C3) -> 4x 200ul glycerols -> glycerol box -20C mmp
RFP+PSB1C3 -> 4x 200ul glycerols/a> ->glycerol box -20C mmp
Minipreped all 4 falcons and a gel was run -> no bands were seen indicating no DNA present.
Item (ul) | IrreAcut | IrreAuc | IrreBcut | IrreBuc | RFPcut | RFPuc | Uncut | Uncut |
---|---|---|---|---|---|---|---|---|
pSB1C3 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
EcoR1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 |
Pst1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 |
Buffer 3 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 |
BSA | 0.5 | 0 | 0.5 | 0 | 0.5 | 0 | 0.5 | 0 |
dH20 | 1.5 | 5 | 1.5 | 5 | 1.5 | 5 | 1.5 | 5 |
Total | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
21st August - Nanodrop of pDNA
Sample | Concentration (ng/ul) | 260/280 |
---|---|---|
Irre A pDNA | -33.0 | 1.74 |
Irre b pDNA | 123.0 | 0.94 |
GFP pDNA | -52.1 | 1.63 |
LB pDNA | -28.4 | 1.34 |
10x cmp plates were made using Yanika's chloramphenicol
Meeting with Darren:
The following Biobricks ordered were brought by our supervisor to be streaked onto the relevant antibiotic plates and inoculated in antibiotic+2mL LB -> Incubate o/n @ 37C.
Biobrick | Plate (+ND) | Inoculation (+ 2mL LB) |
---|---|---|
J63008 | 1X AMP, 1X CMP | 2 mL AMP + 2 mL CMP |
K105028 | 1X AMP | 2 mL AMP |
I712004 | 1X AMP, 1X CMP | 2 mL AMP + 2 mL CMP |
K105030 | 1X AMP | 2 mL AMP |
J63008/9 | 1X AMP | 2 mL AMP |
K105027 | 1X AMP | 2 mL AMP |
K812014 | 1X AMP, 1X CMP | 2 mL AMP + 2 mL CMP |
A PCR of Zeocin was performed and a gel was subsequently ran. PCR tube:
1 - PCR zec bb F, R, 2ul template
2 - PCR zec bb F, R, 1ul template
3 - PCR zec F, R, 2ul template
4 - PCR zec F, R, 1ul template
5 - PCR negative control zec bb F, R,
6 - PCR negative control zec F, R
PCR was unsuccessful
22nd August -
Results from Biobrick streaking and inoculation:
Biobrick | Positive Control (ND) | Cmp plate | Amp plate | Falcon |
---|---|---|---|---|
J63008 | Growth | Growth | No Growth | No Growth |
K105028 | Growth | Growth | Growth | |
K105027 | Growth | Growth | Growth | |
K105030 | Growth | Growth | Growth | |
K812014 | Growth | Growth | Growth | |
J63008/9 | Growth | Growth | Growth | |
I712004 | No Growth | No Growth | No Growth | No Growth |
Glycerol stocks were therefore made from the plates that displayed colony growth.
A second attempt at zeocin PCR was performed using Phusion DNA Polymerase
1 - Zec bb F, R 2ul
2 - Zec bb F, R 1ul
3 - Zec F, R 2ul
4 - Zec F, R 1ul
5 - Negative control zec bb F, R
6 - Negative control zec F, R
A gel was run with 8ul of each of the 6 reactions. PCR was successful.
Restriction digest of the following samples:
A - K105028
B - K105027
C - K105030
D - K812014
E - J63009/8
Double Digest | Uncut | |
---|---|---|
Sample | 5 | 5 |
EcoR1 | 1 | 0 |
Pst1 | 1 | 0 |
Buffer 3 | 1 | 0 |
BSA | 0.5 | 0 |
dH2O | 1.5 | 5 |
Total | 10 | 10 |
Sample | 260/280 | ng/ul |
---|---|---|
K105028 | 2.12 | 39.0 |
K105027 | 1.99 | 47.1 |
K105030 | 2.07 | 48.8 |
K812014 | 1.96 | 113.3 |
J63008/9 | 1.95 | 59.7 |
PCR Purification
1 - zeo bb F, R 2ul template
2 - zeo bb F, R 1ul template
^ stored in iGEM 2013 box
Preparative digest of K812014 (pSB1C3)
Sample | 5ug |
---|---|
E | 7 |
P | 7 |
B3 | 10 |
BSA | 2 |
dH2O | 30 |
Total | 100 |
5ug sample = 44ul of 113.3 ng/ul
CMV PCR
Primers used: 2s + 6FW, 2s + bbRE
23rd August -
Gel was ran with (lane):
(3) PCR purified zeo bb FR + 2ul template
(4) PCR purified zeo bb FR + 1ul template
(6) bwf + bb RE + 1ul template
(7) bwf + bb RE + 2ul template
(8) bwf + bb RE
Samples in lanes 3 & 4 failed, therefore a nanodrop was recorded:
Sample | 260/280 | ng/ul |
---|---|---|
PCR purified zeo bb FR + 2ul template | 1.66 | 55.6 |
PCR purified zeo bb FR + 1ul template | 1.82 | 17.2 |
Mammalian Lab
19th August - Viable cell count data for HeLa growth curve, Day 1 : 0.1 x 10^-6 viable cells per mL
Disc 1 Disc 2
Disc 1 | Disc 2 | Concentration of zeocin (µg/ml) | Confluency (%) | Cell Appearance | Floaters | Confluency (%) | Cell Appearance | Floaters |
---|---|---|---|---|---|---|
0 | 100 | Over confluent | Moderate | 100 | Over confluent | moderate |
50 | 50 | Moderate swelling and death | Many | 80 | Moderate swelling and death | Many |
100 | 20 | severe swelling, death | Many | 20 | severe swelling, death | many |
250 | 0 | - | many | 0 | - | many |
500 | 0 | - | many | 0 | - | many |
1000 | 0 | - | many | 0 | - | many |
Split stock HeLa cells
20th August - Viable cell count data for HeLa growth curve, Day 1 : [0.17, 0.068 (anomaly), 0.23] x 10^-6 viable cells per ml
Disc 1 Disc 2
Disc 1 | Disc 2 | Concentration of zeocin (µg/ml) | Confluency (%) | Cell Appearance | Floaters | Confluency (%) | Cell Appearance | Floaters |
---|---|---|---|---|---|---|
0 | 100 | Over confluent and death | Moderate | 90 | Over confluent | moderate |
50 | 80 | Over confluent, swelling and death | Many | 20 | Moderate swelling and death | Many |
100 | 20 | severe swelling and death | Many | 0 | severe swelling, death | many |
250 | 0 | - | many | 0 | - | many |
500 | 0 | - | many | 0 | - | many |
1000 | 0 | - | many | 0 | - | many |
21st August - Viable cell count data for HeLa growth curve, Day 1 : [0.496, 0.244 (anomaly), 0.356] x 10^-6 viable cells per ml
22nd August - Viable cell count data for HeLa growth curve, Day 1 : [0.79, 1.12, 1.19] x 10^-6 viable cells per ml